Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490191 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
A Phase 4 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 387
- Enrollment target
NCT00490191: Completed Phase 4 study, sponsored by Eli Lilly and Company.
NCT00490191 is a Phase 4 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 387 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (25% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490191, a Phase 4 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 387 participants
- Enrollment target
Study Summary
This study tested whether a dose regimen of growth hormone based on body weight is equivalent or better than starting with a low dose and gradually increasing the dose according to individual patient needs. Efficacy of the two regimens were assessed from changes in body fat measured by dual-energy x-ray absorptiometry (DXA) scanning, performed at the beginning of the study and at the completion of the study eight months later.
Interventions
- DRUG Somatropin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 1999-01 |
| Est. Completion | 2001-07 |
| Phase | Phase 4 |
What the finished NCT00490191 record still lists
NCT00490191 is an interventional study that assigns participants to a tested intervention. The registered 387 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (25% lower).
The record links to 0 conditions, and to 1 intervention - of which Somatropin is the first listed.
NCT00490191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00490191 about?
NCT00490191 is a clinical study titled "Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency". This study tested whether a dose regimen of growth hormone based on body weight is equivalent or better than starting with a low dose and gradually increasing the dose according to individual patient needs. Efficacy of the two regimens were assessed from changes in body fat measured by dual-energy x...
What is the current status of trial NCT00490191?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 387 participants. The study started on 1999-01. Estimated completion is 2001-07.
What interventions are being tested in trial NCT00490191?
The interventions under investigation include: Somatropin (DRUG).
Who is sponsoring clinical trial NCT00490191?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00490191's enrollment target sits among peer trials
387 222nd of 2000 higher than 1,779 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03761108 · 387 participants · Phase 1
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- NCT05572632 · 387 participants · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- NCT06917079 · 387 participants · Phase 1
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia